Innovation in Pediatric Drugs Act of 2025
Senate: Referred
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S1347)
Sign in to view Hilltelligence’s plain-English summary.
Action Timeline
- SenateLatest
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S1347)
- Senate
Introduced in Senate
Sign in to view Hilltelligence’s passage-probability analysis.
Official Sources
Topics
Policy area
Legislative subjects
CancerChild healthCongressional oversightDrug safety, medical device, and laboratory regulationDrug therapyGovernment information and archivesGovernment studies and investigationsMedical researchPrescription drugsResearch administration and funding
Sign in to view Hilltelligence’s potential-cosponsor analysis.